Cipla Q3 Results
- BSE: 500087
- NSE: CIPLA
- ISIN: INE059A01026
- Sector: Biotechnology & Drugs
BSE
1,331.70
2.15 (0.16%)
2.15 (0.16%)Volume19.47 K
Updated: Fri 13 Feb, 2026 | 15:29:58
NSE
1,3311.00 (0.08%)
1.00 (0.08%)Volume1.19 M
Updated: Fri 13 Feb, 2026 | 15:25:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹7,074.48 Cr.(0.02%)
- Operating Profit₹700.80 Cr.(-59.00%)
- Profit After Tax₹675.80 Cr.(-56.97%)
- Operating Margin9.91%(-59.01%)
Note: Comparison is on YoY basis
Quarterly - Cipla Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 6,373.68 | 5,437.17 | 6.38% | 5,284.53 | 18.83% |
| Depreciation/ Amortization | 278.35 | 271.74 | -6.28% | 233.43 | -0.52% |
| Operating Income | 700.80 | 1,613.85 | -56.14% | 1,319.28 | -59.00% |
| Net Income | 675.80 | 1,302.53 | -49.98% | 1,055.90 | -56.97% |
| Other Operating Expenses Total | 1,862.36 | 1,674.54 | -1.06% | 1,568.62 | 14.79% |
| Net Income Before Taxes | 893.11 | 1,789.06 | -51.82% | 1,473.81 | -53.39% |
| Total Revenue | 7,074.48 | 7,051.02 | -6.79% | 6,603.81 | 0.02% |
| Selling/ General/ Admin Expenses Total | 1,324.98 | 1,207.88 | 0.77% | 1,068.13 | 10.63% |
| Diluted Normalized EPS | 10.94 | 16.12 | -34.58% | 14.82 | -43.71% |